Trade Mark Journal No.2024/020 17 May 2024

UK00004036345 8 April 2024 (5)

BEMFARZO

International priority date claimed: 29 November 2023 (United States of America) (98290543)

Class 5: Pharmaceutical and medicated biological preparations for human use.

Bristol-Myers Squibb Company

Representative: Sipara Limited